2007The Journal of Clinical PsychiatryRequires access

Influence of sertraline and clomipramine on quality of life in patients with obsessive-compulsive disorder

Shang Jun-fen

Open publisher page 0 citations

Abstract

Objective:To explore the influence of sertraline and clomipramine on quality of life in patients with obsessive-compulsive disorder.Method:Thirty patients with obsessive-compulsive disorder were treated by sertraline,and the other 30 patients treated by clomipramine.The efficacy and quality of life were measured with Yale-Brown obsessive-compulsive rating scale and general quality of life inventory-74(GQOLI-74)before and after 8 weeks treatment.Results:Compared with clomipramine,sertraline had similar efficacy in the treatment of obsessive-compulsive disorder,with fewer side effects.Quality of life of patients was improved more in sertraline group than in clomipramine group(P0.05).Conclusion:Sertraline can improve the quality of life of obsessive-compulsive disorder patients.

About this research paper

What this paper is about

Objective:To explore the influence of sertraline and clomipramine on quality of life in patients with obsessive-compulsive disorder.Method:Thirty patients with obsessive-compulsive disorder were treated by sertraline,and the other 30 patients treated by clomipramine.The efficacy and quality of life were measured with Yale-Brown obsessive-compulsive rating scale and general quality of life inventory-74(GQOLI-74)before and after 8 weeks treatment.Results:Compared with clomipramine,sertraline had similar efficacy in the treatment of obsessive-compulsive disorder,with fewer side effects.Quality of life of patients was improved more in sertraline group than in clomipramine group(P0.05).Conclusion:Sertraline can improve the quality of life of obsessive-compulsive disorder patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the influence of sertraline and clomipramine on quality of life in patients with obsessive-compulsive disorder.Method:Thirty patients with obsessive-compulsive disorder were treated by sertraline,and the other 30 patients treated by clomipramine.The efficacy and quality of life were measured with Yale-Brown obsessive-compulsive rating scale and general quality of life inventory-74(GQOLI-74)before and after 8 weeks treatment.Results:Compared with clomipramine,sertraline had similar efficacy in the treatment of obsessive-compulsive disorder,with fewer side effects.Quality of life of patients was improved more in sertraline group than in clomipramine group(P0.05).Conclusion:Sertraline can improve the quality of life of obsessive-compulsive disorder patients.

Key concepts: Clomipramine, Sertraline, Quality of life (healthcare), Obsessive compulsive, Psychology, Rating scale, Psychiatry, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence of sertraline and clomipramine on quality of life in patients with obsessive-compulsive disorder — Research Paper | ScholarLens